by rdbiomed | Oct 12, 2020 | LPR, pepsin
Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study. LPR symptoms typically consist of hoarseness, sore throat, the feeling of a lump in the throat and throat clearing. However, it is also... 
by rdbiomed | Sep 14, 2020 | LPR, pepsin
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed. Many non-essential medical procedures have been postponed or cancelled during the Covid-19 pandemic, with... 
by rdbiomed | May 28, 2020 | pepsin, reflux
Diagnostic device Peptest has been used to help researchers investigate a potential link between salivary pepsin levels and tooth erosion. Dental erosion – the loss of tooth enamel – has often been associated with reflux disease due to direct contact between tooth... 
by rdbiomed | May 22, 2020 | GERD, pepsin
Salivary pepsin could potentially be used as a non-invasive marker of reflux aspiration in children with gastro-oesophageal reflux disease (GORD) – a new study has shown. Reflux aspiration secondary to GORD/ GERD is one of the causes of chronic gastrointestinal and... 
by rdbiomed | Feb 27, 2020 | GERD, pepsin
Testing saliva for the stomach enzyme pepsin can help speed up the management of reflux, a new research study has concluded. Peptest – a salivary pepsin test – is also described as an ‘important diagnostic tool’ for gastro-oesophageal reflux disease (GORD/ GERD) and... 
by Peter Dettmar | Aug 4, 2019 | Company News, pepsin
An evaluation of the current literature on pepsin from its discovery and structure to the comparison of concentration between adults and newborns has recently been published in the internationally peer reviewed journal EC Gastroenterology and Digestive System (ECGDS)....
Recent Comments